24HourWire

Another Option for Rare Benign Soft-Tissue Tumor Wins FDA Approval

(MedPage Today) -- The FDA approved the small-molecule inhibitor pimicotinib (Pimjetmi) for selected patients with symptomatic tenosynovial giant cell tumor (TGCT) and high surgical risk. An oral sel…